Judith A. Aberg, MD

Poster(s):

• 510 - Elevated IL-1β level as a predictor of inflammation and death in COVID-19

• 548 - Baseline characteristics associated with clinical improvement and mortality in hospitalized patients with moderate COVID-19

• 557 - Impact of Concomitant Hydroxychloroquine Use on Safety and Efficacy of Remdesivir in Moderate COVID-19 Patients

• 561 - Safety of Remdesivir vs Standard Care in Patients with Moderate Covid-19

• 935 - Effect of Tesamorelin in People with HIV with and without Dorsocervical Fat: Post Hoc Analysis of Phase III Double Blind Placebo Control Trial